papaverine has been researched along with vinpocetine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Bucki, A; Chłoń-Rzepa, G; Funk, P; Gawalska, A; Lemrová, B; Nowak, B; Pawłowski, M; Pociecha, K; Ručilová, V; Soural, M; Świerczek, A; Vanda, D; Wyska, E; Zadrożna, M; Zajdel, P | 1 |
Akopov, SE; Gabrielian, ES; Sarkisian, SB | 1 |
Forssmann, WG; Hess, R; Jonas, U; Schulz-Knappe, P; Stief, CG; Truss, MC; Uckert, S | 1 |
Cantabrana, B; Hidalgo, A; Perez-Vallina, JR; Revuelta, MP | 1 |
Aardal, S; Helle, KB; Lillestłl, IK | 1 |
Sawada, M; Suzumura, A; Takayanagi, T; Tamaru, T; Yoshikawa, M | 1 |
Bulaeva, SV; Chuchkanov, FA; Maimistova, AA; Muravyov, AV; Yakusevich, VV; Zaitsev, LG | 1 |
Horvath, B; Kesmarky, G; Toth, K; Vekasi, J | 1 |
9 other study(ies) available for papaverine and vinpocetine
Article | Year |
---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases.
Topics: Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Cyclic Nucleotide Phosphodiesterases, Type 7; Disease Models, Animal; Female; Humans; Imidazoles; Inflammation; Male; Mice, Inbred BALB C; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pyridines; Rats, Wistar | 2021 |
[Approaches to the creation of a model of cerebral thrombocytic microembolism and to research on the effects of drugs].
Topics: Acid-Base Equilibrium; Animals; Blood Pressure; Cats; Collagen; Disease Models, Animal; Drug Evaluation, Preclinical; Epoprostenol; Fibrinolytic Agents; Intracranial Embolism and Thrombosis; Methods; Papaverine; Platelet Aggregation; Vasodilator Agents; Verapamil; Vinca Alkaloids | 1987 |
Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Calmodulin; Carbachol; Chromatography, Affinity; Chromatography, Agarose; In Vitro Techniques; Isoenzymes; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Papaverine; Phosphodiesterase Inhibitors; Purinones; Pyrrolidinones; Rolipram; Swine; Urinary Bladder; Vinca Alkaloids | 1995 |
Effect of Rp diastereoisomer of adenosine 3',5' cyclic-monophosphothioate on the cAMP-dependent relaxation of smooth muscle.
Topics: Animals; Colforsin; Cyclic AMP; Drug Interactions; Enzyme Inhibitors; Female; Histamine; Muscle Relaxation; Papaverine; Phosphodiesterase Inhibitors; Potassium Chloride; Pyrrolidinones; Rats; Rats, Wistar; Rolipram; Stereoisomerism; Thionucleotides; Uterine Contraction; Uterus; Vanadates; Vinca Alkaloids | 1997 |
Relaxing effects of cyclic GMP and cyclic AMP-enhancing agents on the long-lasting contraction to endothelin-1 in the porcine coronary artery.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Atrial Natriuretic Factor; Caffeine; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Colforsin; Coronary Vessels; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Endothelin-1; In Vitro Techniques; Isradipine; Milrinone; Muscle, Smooth, Vascular; Papaverine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Pyrrolidinones; Rolipram; Swine; Vasoactive Intestinal Peptide; Vasoconstriction; Vasodilation; Verapamil; Vinca Alkaloids | 1998 |
Effects of phosphodiesterase inhibitors on cytokine production by microglia.
Topics: 1-Methyl-3-isobutylxanthine; Amrinone; Animals; Anti-Ulcer Agents; Cilostazol; Colforsin; Dipyridamole; DNA Primers; Gene Expression Regulation, Enzymologic; Interleukin-1; Interleukin-6; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazines; Pyrrolidinones; Quinolines; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Rolipram; Tetrazoles; Theophylline; Tumor Necrosis Factor-alpha; Vinca Alkaloids; Xanthines | 1999 |
Hemorheological efficiency of drugs, targeting on intracellular phosphodiesterase activity: in vitro study.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Blood Viscosity; Caffeine; Calcimycin; Calcium; Egtazic Acid; Erythrocyte Aggregation; Hemorheology; Humans; Male; Nifedipine; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Verapamil; Vinca Alkaloids | 2007 |
In vitro antioxidant properties of pentoxifylline and vinpocetine in a rheological model.
Topics: Adult; Blood Viscosity; Caffeine; Calcimycin; Calcium; Egtazic Acid; Erythrocyte Aggregation; Free Radical Scavengers; Hemorheology; Humans; Male; Nifedipine; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Verapamil; Vinca Alkaloids | 2008 |